zintick

Starling Oncology STLN

Starling Oncology, Inc. · Nasdaq · Services-Offices & Clinics of Doctors of Medicine · also STLNW

$3.62-45.97%close on Nov. 6, 2026 · volume 23.9M · Yahoo Finance

Price, last 54 sessions

$4.00$5.00$6.00$7.00Sept. 2026Oct. 2026Nov. 2026
Aug. 24, 2026 to Nov. 6, 2026 · high $7.05 · low $3.62 · SEC filing, placed when SEC released it

Our coverage

Nothing published yet.

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Aug. 21, 2026Brad Hively
director
Sold
10b5-1 plan
298,853$6.51$1.95 million
Aug. 14, 2026Jorey Chernett
10% owner
Bought12,000$6.54$78,480

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 16 →
  • 10-QNov. 5, 2026, 6:03 p.m. ETView on SEC.gov
  • 8-KNov. 5, 2026, 4:57 p.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits

    AI summary, unreviewedStarling Oncology Q3 2026 revenue of $169.8 million tops $168.7 million consensus, but GAAP EPS of -$0.13 misses -$0.048 and FY2026 revenue guidance is cut to $650-660 million

  • 8-KSept. 1, 2026, 8:41 p.m. ETView on SEC.gov

    Departure/appointment of directors or officers

  • 4Aug. 24, 2026, 5:11 p.m. ETView on SEC.gov
  • 8-KAug. 21, 2026, 5:25 p.m. ETView on SEC.gov

    Entry into a material definitive agreement · Creation of a direct financial obligation · Financial statements and exhibits

  • 4Aug. 17, 2026, 10:13 a.m. ETView on SEC.gov
  • 10-QAug. 6, 2026, 4:36 p.m. ETView on SEC.gov
  • 8-KAug. 6, 2026, 4:32 p.m. ETView on SEC.gov

    Results of operations and financial condition · Financial statements and exhibits